Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PAAD | rs73311676 | chr17:40293882 | C/T | 0.000115 | 178 | 15.57 | 12.93 | 4 | KM Plot |
PAAD | rs73311686 | chr17:40305542 | G/A | 8.84E-5 | 177 | 15.57 | 13.8 | 4 | KM Plot |
PAAD | rs73319227 | chr5:172101005 | C/T | 7.62E-5 | 176 | 15.37 | 16.03 | 3.9 | KM Plot |
PAAD | rs73319228 | chr5:172101173 | T/G | 7.62E-5 | 176 | 15.37 | 16.03 | 3.9 | KM Plot |
PAAD | rs7336332 | chr13:28058404 | A/G | 1.09E-6 | 175 | 15.37 | 16.13 | 3.5 | KM Plot |
PAAD | rs733855 | chr1:16324881 | A/G | 1.97E-6 | 176 | 3.43 | 15.53 | 15.5 | KM Plot |
PAAD | rs7342231 | chr11:49772761 | A/G | 1.62E-5 | 178 | 15.4 | 15.77 | 0.4 | KM Plot |
PAAD | rs7355266 | chr2:240847001 | G/A | 9.52E-6 | 171 | 15.67 | 14.18 | 4.47 | KM Plot |
PAAD | rs7355568 | chr2:240846769 | C/G | 9.52E-6 | 171 | 15.67 | 14.18 | 4.47 | KM Plot |
PAAD | rs73618920 | chr11:125569361 | T/C | 4.48E-5 | 177 | 16.05 | 11.6 | 4.1 | KM Plot |
PAAD | rs73625121 | chr11:125593849 | C/A | 9.4E-5 | 178 | 16.1 | 14.18 | 5.03 | KM Plot |
PAAD | rs73625135 | chr11:125597688 | C/T | 0.00011 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |
PAAD | rs73625136 | chr11:125597797 | T/C | 0.00011 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |
PAAD | rs73625138 | chr11:125598031 | A/G | 0.00011 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |
PAAD | rs73625139 | chr11:125598194 | G/A | 0.00011 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |